Shalina Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 23-06-2024
- Paid Up Capital ₹ 25.00 K
as on 23-06-2024
- Company Age 3 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
About Shalina Pharmaceuticals
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 25.00 K , as per Ministry of Corporate Affairs (MCA) records.
Sundar Sankaran, Fazle Virji, Shalina Clifford, and One other member serve as directors at the Company.
- CIN/LLPIN
U24299MH2021PTC364251
- Company No.
364251
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Jul 2021
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Shalina Pharmaceuticals?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sundar Sankaran  | Nominee Director | 20-Jul-2021 | Current |
Fazle Virji  | Director | 24-Sep-2021 | Current |
| Shalina Clifford | Director | 24-Sep-2021 | Current |
| Prasad Deshpande | Additional Director | 12-Feb-2024 | Current |
Financial Performance and Corporate Structure Insights of Shalina Pharmaceuticals.
Enhance accessibility to Shalina Pharmaceuticals's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Shalina Pharmaceuticals?
Unlock access to Shalina Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Shalina Laboratories Private LimitedActive 4 years 3 monthsSundar Sankaran, Fazle Virji and 2 more are mutual person
Shalina Trading Co Pvt LtdActive 43 years 5 monthsSundar Sankaran and Prasad Deshpande are mutual person
Advantage-India Consulting Private LimitedActive 24 years 11 monthsSundar Sankaran is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Shalina Pharmaceuticals?
Unlock and access historical data on people associated with Shalina Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shalina Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shalina Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
